Related Experiment Video
Updated: Mar 11, 2026

Capturing Common Fragile Site Breaks by Native γH2A.X ChIP
Published on: January 24, 2025
Excessive Cytosolic DNA Fragments as a Potential Trigger of Graves' Disease: An Encrypted Message Sent by Animal
Yuqian Luo1, Aya Yoshihara2, Kenzaburo Oda3
1Department of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University , Tokyo , Japan.
Abstract:
Graves' hyperthyroidism is caused by autoantibodies directed against the thyroid-stimulating hormone receptor (TSHR) that mimic the action of TSH. The establishment of Graves' hyperthyroidism in experimental animals has proven to be an important approach to dissect the mechanisms of self-tolerance breakdown that lead to the production of thyroid-stimulating TSHR autoantibodies (TSAbs). "Shimojo's model" was the first successful Graves' animal model, wherein immunization with fibroblasts cells expressing TSHR and a major histocompatibility complex (MHC) class II molecule, but not either alone, induced TSAb production in AKR/N (H-2k) mice. This model highlights the importance of coincident MHC class II expression on TSHR-expressing cells in the development of Graves' hyperthyroidism. These data are also in agreement with the observation that Graves' thyrocytes often aberrantly express MHC class II antigens via mechanisms that remain unclear. Our group demonstrated that cytosolic self-genomic DNA fragments derived from sterile injured cells can induce aberrant MHC class II expression and production of multiple inflammatory cytokines and chemokines in thyrocytes in vitro, suggesting that severe cell injury may initiate immune responses in a way that is relevant to thyroid autoimmunity mediated by cytosolic DNA signaling. Furthermore, more recent successful Graves' animal models were primarily established by immunizing mice with TSHR-expressing plasmids or adenovirus. In these models, double-stranded DNA vaccine contents presumably exert similar immune-activating effect in cells at inoculation sites and thus might pave the way toward successful Graves' animal models. This review focuses on evidence suggesting that cell injury-derived self-DNA fragments could act as Graves' disease triggers.
Insights
Cell injury-derived DNA fragments may trigger Graves' disease. This research explores how self-DNA from damaged cells can initiate autoimmune responses, leading to thyroid-stimulating hormone receptor (TSHR) autoantibodies and hyperthyroidism.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Graves' hyperthyroidism stems from autoantibodies targeting the thyroid-stimulating hormone receptor (TSHR), mimicking TSH action.
- Establishing animal models is crucial for understanding the breakdown of self-tolerance in producing these thyroid-stimulating TSHR autoantibodies (TSAbs).
Approach:
- Reviews evidence from early models like "Shimojo's model" using TSHR-expressing fibroblasts and MHC class II molecules.
- Examines recent models utilizing TSHR-expressing plasmids or adenovirus, highlighting the role of DNA in immune activation.
- Discusses in vitro findings where cytosolic self-genomic DNA induces aberrant MHC class II expression and cytokine production in thyrocytes.
Key Points:
- Coincident expression of MHC class II on TSHR-expressing cells is vital for TSAb production.
- Aberrant MHC class II expression on Graves' thyrocytes suggests a link to underlying cellular mechanisms.
- Cytosolic DNA from injured cells may initiate autoimmune responses relevant to thyroid autoimmunity.
Conclusions:
- Severe cell injury and subsequent release of self-DNA fragments are proposed as potential triggers for Graves' disease.
- This perspective integrates findings from various animal models and in vitro studies to explain disease initiation.
More Related Videos
11:03High Throughput Measurement of Extracellular DNA Release and Quantitative NET Formation in Human Neutrophils In Vitro
Published on: June 18, 2016
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019